Marpai, Inc. (MRAI)
OTCMKTS
· Delayed Price · Currency is USD
1.600
+0.050 (3.23%)
Nov 15, 2024, 4:00 PM EST
Marpai Revenue
Marpai had revenue of $7.01M in the quarter ending September 30, 2024, a decrease of -19.72%. This brings the company's revenue in the last twelve months to $30.29M, down -16.04% year-over-year. In the year 2023, Marpai had annual revenue of $37.16M with 52.64% growth.
Revenue (ttm)
30.29M
Revenue Growth
-16.04%
P/S Ratio
0.53
Revenue / Employee
186.97K
Employees
162
Market Cap
21.98M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 37.16M | 12.81M | 52.64% |
Dec 31, 2022 | 24.34M | 10.12M | 71.10% |
Dec 31, 2021 | 14.23M | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
Marpai News
- 4 days ago - Marpai, Inc (MRAI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 days ago - MARPAI REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS - PRNewsWire
- 8 days ago - MARPAI TO HOST WEBCAST ON NOVEMBER 12, 2024 TO DISCUSS THIRD QUARTER 2024 FINANCIAL RESULTS - PRNewsWire
- 2 months ago - MARPAI ANNOUNCES NEW "OFF CYCLE" CLIENT CONTRACT - PRNewsWire
- 3 months ago - Marpai, Inc. (MRAI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - MARPAI REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS - PRNewsWire
- 3 months ago - MARPAI TO HOST WEBCAST ON AUGUST 8, 2024 TO DISCUSS SECOND QUARTER 2024 FINANCIAL RESULTS - PRNewsWire
- 4 months ago - MARPAI PRESIDENT JOHN POWERS TABBED TO SPEAK AT 3 ELITE HEALTHCARE CONFERENCES - PRNewsWire